Arcutis Biotherapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $142k | 44k | 3.23 |
| 2023-09-30 | $144k | 27k | 5.31 |
| 2023-06-30 | $259k | 27k | 9.53 |
| 2023-03-31 | $239k | 22k | 11.00 |
| 2022-12-31 | $322k | 22k | 14.80 |
| 2022-09-30 | $416k | 22k | 19.11 |
| 2022-06-30 | $356k | 17k | 21.29 |
| 2022-03-31 | $322k | 17k | 19.26 |
| 2021-12-31 | $219k | 11k | 20.74 |
| 2021-09-30 | $252k | 11k | 23.89 |
| 2021-06-30 | $288k | 11k | 27.29 |
| 2021-03-31 | $239k | 8.2k | 28.93 |
| 2020-12-31 | $232k | 8.2k | 28.14 |
| 2020-09-30 | $242k | 8.2k | 29.35 |
| 2020-06-30 | $162k | 5.3k | 30.33 |
| 2020-03-31 | $159k | 5.3k | 29.76 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors